Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126978152 | 12697815 | 2 | F | 20160226 | 20160912 | 20160830 | 20160914 | PER | US-SHIRE-US201610456 | SHIRE | 5.51 | YR | M | Y | 19.60000 | KG | 20160914 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126978152 | 12697815 | 1 | PS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Oral | 20-40 MG, 1X/DAY:QD | 21977 | CAPSULE | QD | ||||||||
126978152 | 12697815 | 2 | C | FLONASE /00908302/ | MOMETASONE FUROATE | 1 | UNK UNK, AS REQ'D | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126978152 | 12697815 | 1 | Attention deficit/hyperactivity disorder |
126978152 | 12697815 | 2 | Seasonal allergy |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126978152 | 12697815 | Drug administered to patient of inappropriate age | |
126978152 | 12697815 | No adverse event |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126978152 | 12697815 | 1 | 20160226 | 0 |